These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35325923)

  • 1. Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
    Doll MK; Pettigrew SM; Ma J; Verma A
    Clin Infect Dis; 2022 Aug; 75(1):e564-e571. PubMed ID: 35325923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
    Turbyfill C; Adams K; Tenforde MW; Murray NL; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Keipp Talbot H; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Clark Files D; Hager DN; Shehu A; Prekker ME; Frosch AE; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Lauring AS; Khan A; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; June Gordon A; Qadir N; Chang SY; Mallow C; Rivas C; Kwon JH; Halasa N; Chappell JD; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Rhoads JP; Lindsell CJ; Hart KW; McMorrow M; Surie D; Self WH; Patel MM
    Vaccine; 2022 Nov; 40(48):6979-6986. PubMed ID: 36374708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.
    Shi M; An Q; Ainslie KEC; Haber M; Orenstein WA
    BMC Infect Dis; 2017 Dec; 17(1):757. PubMed ID: 29216845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design.
    Payne AB; Ciesla AA; Rowley EAK; Weber ZA; Reese SE; Ong TC; Vazquez-Benitez G; Naleway AL; Klein NP; Embi PJ; Grannis SJ; Kharbanda AB; Gaglani M; Tenforde MW; Link-Gelles R;
    Vaccine; 2023 Dec; 41(51):7581-7586. PubMed ID: 38000964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the bias of estimates of influenza vaccine effectiveness from test-negative studies.
    Ainslie KEC; Shi M; Haber M; Orenstein WA
    Vaccine; 2017 Dec; 35(52):7297-7301. PubMed ID: 29146382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network.
    Tenforde MW; Weber ZA; DeSilva MB; Stenehjem E; Yang DH; Fireman B; Gaglani M; Kojima N; Irving SA; Rao S; Grannis SJ; Naleway AL; Kirshner L; Kharbanda AB; Dascomb K; Lewis N; Dalton AF; Ball SW; Natarajan K; Ong TC; Hartmann E; Embi PJ; McEvoy CE; Grisel N; Zerbo O; Dunne MM; Arndorfer J; Goddard K; Dickerson M; Patel P; Timbol J; Griggs EP; Hansen J; Thompson MG; Flannery B; Klein NP
    J Infect Dis; 2023 Jul; 228(2):185-195. PubMed ID: 36683410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of selection bias on vaccine effectiveness estimates from test-negative studies.
    Jackson ML; Phillips CH; Benoit J; Kiniry E; Madziwa L; Nelson JC; Jackson LA
    Vaccine; 2018 Jan; 36(5):751-757. PubMed ID: 29254838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.
    Ainslie KEC; Haber M; Orenstein WA
    Vaccine; 2019 Mar; 37(14):1987-1993. PubMed ID: 30833155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
    Lanièce Delaunay C; Martínez-Baz I; Sève N; Domegan L; Mazagatos C; Buda S; Meijer A; Kislaya I; Pascu C; Carnahan A; Oroszi B; Ilić M; Maurel M; Melo A; Sandonis Martín V; Trobajo-Sanmartín C; Enouf V; McKenna A; Pérez-Gimeno G; Goerlitz L; de Lange M; Rodrigues AP; Lazar M; Latorre-Margalef N; Túri G; Castilla J; Falchi A; Bennett C; Gallardo V; Dürrwald R; Eggink D; Guiomar R; Popescu R; Riess M; Horváth JK; Casado I; García MDC; Hooiveld M; Machado A; Bacci S; Kaczmarek M; Kissling E;
    Euro Surveill; 2024 Mar; 29(13):. PubMed ID: 38551095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates From Observational Studies.
    Ainslie KEC; Shi M; Haber M; Orenstein WA
    Am J Epidemiol; 2019 Feb; 188(2):451-460. PubMed ID: 30329006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of self-reported vaccination status can bias vaccine effectiveness estimates from test-negative studies.
    Jackson ML
    Vaccine X; 2019 Apr; 1():100003. PubMed ID: 33826685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
    Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
    Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the 2019-2020 Influenza Vaccine and the Effect of Prior Influenza Infection and Vaccination in Children during the First Influenza Season Overlapping with the COVID-19 Epidemic.
    Ando S
    J Nippon Med Sch; 2021 Dec; 88(6):524-532. PubMed ID: 33692300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness.
    Jackson ML; Rothman KJ
    Vaccine; 2015 Mar; 33(11):1313-6. PubMed ID: 25659280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The test-negative design for estimating influenza vaccine effectiveness.
    Jackson ML; Nelson JC
    Vaccine; 2013 Apr; 31(17):2165-8. PubMed ID: 23499601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine effectiveness against hospitalization due to SARS-CoV-2: A test-negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain.
    Mazagatos C; Delgado-Sanz C; Monge S; Pozo F; Oliva J; Sandonis V; Gandarillas A; Quiñones-Rubio C; Ruiz-Sopeña C; Gallardo-García V; Basile L; Barranco-Boada MI; Hidalgo-Pardo O; Vazquez-Cancela O; García-Vázquez M; Fernández-Sierra A; Milagro-Beamonte A; Ordobás M; Martínez-Ochoa E; Fernández-Arribas S; Lorusso N; Martínez A; García-Fulgueiras A; Sastre-Palou B; Losada-Castillo I; Martínez-Cuenca S; Rodríguez-Del Águila M; Latorre M; Larrauri A;
    Influenza Other Respir Viruses; 2022 Nov; 16(6):1014-1025. PubMed ID: 35880469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies.
    Haber M; An Q; Foppa IM; Shay DK; Ferdinands JM; Orenstein WA
    Epidemiol Infect; 2015 May; 143(7):1417-26. PubMed ID: 25147970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings.
    Foppa IM; Ferdinands JM; Chaves SS; Haber MJ; Reynolds SB; Flannery B; Fry AM
    Int J Epidemiol; 2016 Dec; 45(6):2052-2059. PubMed ID: 26979985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of inactivated influenza and COVID-19 vaccines in hospitalized children in 2022/23 season in Japan - The first season of co-circulation of influenza and COVID-19.
    Shinjoh M; Furuichi M; Tsuzuki S; Iqbal A; Fukushima N; Soen S; Fukushima H; Kobayashi K; Yamada G; Narabayashi A; Tsunematsu K; Maeda N; Shimoyamada M; Yoshida M; Kuramochi Y; Shibata A; Yamaguchi Y; Yaginuma M; Takahashi T; Ishikane M; Sugaya N;
    Vaccine; 2023 Jul; 41(33):4777-4781. PubMed ID: 37419851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.